ARAY stock forecast
Our latest prediction for Accuray, Inc.'s stock price was made on the Dec. 4, 2019 when the stock price was at 2.76$.
In the short term (2weeks), ARAY's stock price should underperform the market by -4.05%. During that period the price should oscillate between -9.20% and +10.11%.
In the medium term (3months), ARAY's stock price should underperform the market by -10.34%. During that period the price should oscillate between -28.46% and +21.04%.Get email alerts
About Accuray, Inc.
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
At the moment the company generates 413M USD in revenues.
On its last earning announcement, the company reported a loss of -0.19$ per share.
The book value per share is 0.56$
Three months stock forecastDec. 4, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|